Polymarket Responds to High Fee Rate Controversy: Admits a Calculation Error, Fixes It, and Removes the Abnormal Fees

Gate News Update: April 1, the Polymarket team is expected to post an announcement on Discord, addressing the community’s earlier concerns that some category fees were too high. The team admitted that, during adjustments to optimize the fee curve, they mistakenly used the taker traded volume denominated in dollars for the calculation. The method has now been changed to use “share quantity.” This approach is an industry-standard practice and can effectively eliminate fee imbalances.

The team said that, in weather and economic markets, the combination of the above calculation error and an additional introduced index caused the fee curve to become severely distorted. In particular, abnormal high fees appeared in low-price ranges (such as 0.1 cent), which is also the main reason behind the recent social media controversy over “super high fees.” The platform has now revised the fee schedule and removed the related index, and the fee structure for all markets has returned to normal.

In addition, the team suggested that fee-sensitive users can achieve zero-fee trades by placing limit orders. With the latest update now live, users can also receive a maker rebate incentive of 20% to 25%.

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.
Comment
0/400
No comments